Loading...
Market
First organization to fund large-scale study on COVID-19 and type 2 diabetes in children by end of 2025?
3
Resolution / Starting Odds
NIH • 25%
WHO • 25%
CDC • 25%
Other • 25%
Announcements from funding organizations or research institutions
Story
Study by American Medical Association Links COVID-19 Infection to 45% Increased Risk of Type 2 Diabetes in Children, 2020 to 2022
Oct 15, 2024, 01:03 PM
A recent observational study published by the American Medical Association suggests that COVID-19 infection may be linked to an increased risk of developing type 2 diabetes in children and adolescents. The study indicates a 45% increase in relative risk of type 2 diabetes within one month following a COVID diagnosis. Experts note that the metabolic stress caused by COVID-19 could exacerbate pre-existing vulnerabilities in susceptible youth. The findings have sparked debate within the medical community, with some questioning the rapid onset of diabetes post-infection and the mechanisms by which a respiratory virus could affect pancreatic function. The study, titled 'SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022,' underscores the need for further research into the long-term health impacts of COVID-19 on young populations.
View original story
Similar markets
NIH • 25%
CDC • 25%
Bill & Melinda Gates Foundation • 25%
Other • 25%
National Institutes of Health (NIH) • 25%
World Health Organization (WHO) • 25%
Bill & Melinda Gates Foundation • 25%
Other • 25%
National Institutes of Health (NIH) • 25%
Bill & Melinda Gates Foundation • 25%
Wellcome Trust • 25%
Howard Hughes Medical Institute • 25%
National Institutes of Health (NIH) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
Private Foundations • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Genetic research • 25%
Clinical trials • 25%
Data infrastructure • 25%
Other • 25%
Yes • 50%
No • 50%
Lifestyle modification programs • 25%
Medication • 25%
Regular screening • 25%
Other • 25%
Majority to existing programs • 25%
Majority to new initiatives • 25%
Even split between existing and new • 25%
Other allocation strategy • 25%
Inflammation • 25%
Obesity • 25%
Genetic predisposition • 25%
Other • 25%
